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We have used a unique polymorphic 3′ transduction to show that a human L1, or LINE-1 (long interspersed nucleotide
element–1), retrotransposition event most likely occurred in the maternal primary oocyte during meiosis I. We char-
acterized a truncated L1 retrotransposon with a 3′ transduction that was inserted, in a Dutch male patient, into the
X-linked gene CYBB, thereby causing chronic granulomatous disease. We used the unique flanking sequence to localize
the precursor L1 locus, LRE3, to chromosome 2q24.1. In a cell culture assay, the retrotransposition frequency of
LRE3 is greater than that for any other element that has been tested to date. The patient’s mother had two LRE3
alleles that differed slightly in the 3′-flanking genomic DNA. The patient had a single LRE3 allele that was identical
to one of the maternal alleles; however, the patient’s insertion matched the maternal LRE3 allele that he did not
inherit. Other data indicate that there is only a small chance that the father (unavailable for analysis) carries the
precursor LRE3 allele. In addition, paternal origin of the insertion would have required that an LRE3 mRNA
transcribed before meiosis II be carried separately from its precursor LRE3 allele in the fertilizing sperm. Since the
mother carries a potential precursor allele and the insertion was on the patient’s maternal X chromosome, it is
highly likely that the insertion originated during maternal meiosis I.
Introduction
Preliminary analysis of the human genome has shown that
transposable elements compose45% of its mass (Land-
er et al. 2001). L1, or LINE-1 (long interspersed nucle-
otide element–1), retrotransposons are one of the most
successful transposable elements, comprising 17% of the
genome (Lander et al. 2001). Most of the ∼500,000 L1
copies present in the human genome are truncated at their
5′ end, rearranged by inversion, and/or mutated. Only a
small percentage are full length (Lander et al. 2001), and
only 40–80 potentially are retrotranspositionally active
(Sassaman et al. 1997). In humans, the youngest and most
active elements belong to the Ta-1d subset (Boissinot et
al. 2000). The insertion reported here is the 14th-known
recent L1 insertion in humans (Ostertag and Kazazian
2001). However, 170% of these insertions were ascer-
tained by the presence of X-linked disease in male patients
(Ostertag and Kazazian 2001). Estimates of the actual
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frequency of L1 insertions range from 1 in 10 to 1 in 120
individuals (Kazazian 1999; Li et al. 2001).
An intact, full-length human L1 element is ∼6.1 kb
and contains (1) a 5′ UTR that is followed by two non-
overlapping ORFs, (2) a 3′ UTR with a polyadenylation
signal, and (3) a polyA tail (Scott et al. 1987). The ele-
ment encodes endonuclease and reverse-transcriptase ac-
tivities in ORF2 (Mathias et al. 1991; Feng et al. 1996)
and duplicates by the following mechanism (the details
of which are largely unknown): First, the original retro-
transposon is maintained, in situ, where it is transcribed
(Whitcomb and Hughes 1992; Luan et al. 1993). Then,
the transcript is reverse transcribed and integrated into
a new genomic location by a process termed “target-
primed reverse transcription” (Luan et al. 1993). Finally,
on integration, the L1 element typically is flanked by
target-site duplications (TSDs) of 6–20 bp; the integra-
tion site has a weak consensus sequence (5′-Py-Py/AAAA-
3′) (Cost and Boeke 1998), and L1 elements appear to
be inserted at random locations in the genome (Ovchin-
nikov et al. 2001).
There are exceptions to the canonical retrotransposi-
tion event. For example, L1 elements often transduce
DNA flanking their 3′ ends. In ∼20% of cases, the L1
polyA signal is skipped in favor of a downstream polyA
signal (Holmes et al. 1994; Goodier et al. 2000; Pickeral
et al. 2000). In one previous instance, unique transduced
sequence was used to find and characterize the precursor
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to a human L1 insertion (Holmes et al. 1994). Also, L1
elements can be inserted into the genome without a TSD
(Narita et al. 1993; Jensen et al. 1994).
Little is known about either the timing of human retro-
transposition events or the cell types in which such events
occur. From an evolutionary standpoint, retrotransposi-
tion in a germline or a germline precursor is necessary.
In tissue culture, it has been shown that retrotransposi-
tion from an episome is possible in several transformed
cell lines—including feline G355.5 cells (Esnault et al.
2000); human HeLa (Moran et al. 1996), 143B TK
(thymidine kinase negative; American Type Culture Col-
lection number CRL-8303), and H460 cells (E.O., un-
published data); and mouse LTK cells (Moran et al. 1996;
Naas et al. 1998). Our laboratory has failed to demon-
strate retrotransposition in primary cell lines, including
mouse embryonic fibroblasts and human fibroblasts (au-
thors’ unpublished data). In a transgenic mouse model,
we have, by reverse-transcriptase PCR, found L1 mRNA
in spermatocytes, and we have shown retrotransposition
in male germ cells (Ostertag et al. 2000). It has also been
shown that ORF1 is expressed in mouse testis (sper-
matocytes, myoid cells, and Leydig cells) and ovaries,
as well as in steroidogenic cells (Branciforte and Mar-
tin 1994; Trelogan and Martin 1995). Finally, in one
instance, an L1 insertion into the APC gene caused
colon cancer in a human (Miki et al. 1992). However,
to date, it has not been possible to define the timing
and cell type of a heritable human retrotransposition
event. Here, we present data that strongly suggest that
an L1 insertion occurred during maternal meiosis I.
Subject and Methods
Patient History
The patient was born in 1980 and presented, in the 1st
year of life, with multiple infectious complications—in-
cluding recurrent pneumonia—as well as abscesses of the
perianal region, liver, and lymph nodes. After diagnosis
of chronic granulomatous disease (CGD [MIM 306400])
at 15 mo of age, prophylactic treatment with cotrimox-
azole was initiated. Pneumonia caused by Aspergillus
pneumoniae at the age of 22 mo led to treatment by the
addition of itraconazole to the prophylactic protocol. Un-
der this regimen, the patient remained infection free until
1999, when he presented again with pneumonia, leading
to his hospitalization, that was caused by A. pneumoniae.
Ensuing complications included several episodes of bac-
terial sepsis; fungal lesions in lungs, liver, and spleen; os-
teomyelitis; and proctitis. Currently, he is infection free
and is followed as an outpatient.
Diagnosis of CGD
Diagnosis of CGD was achieved by analysis of gran-
ulocyte function, nitroblue tetrazolium (NBT) test, deter-
mination of cytochrome b558 content in whole and Triton
X100–extracted cells, and monocyte hybridization, which
were performed as described elsewhere (Weening et al.
1985).
PCR
Amplification of CYBB.—The 13 exons of CYBB, in-
cluding their adjacent intronic sequences (namely, exon 1
and promoter sequences), were amplified as described
elsewhere (Meischl et al. 2000). In brief, genomic DNA
(50–500 ng) was amplified by use of the Rapid Cycler
(Idaho Technology), with 50 cycles of 95C for 5 s, 60C
for 30 s, and 72 C for 15 s and slope S9. The reaction
volume of 15 ml contained 2 U of Taq DNA polymerase
(Promega), 2 U of TaqStart antibody (Clontech Labora-
tories), 50 ng of each primer, 200 mM of each of the
deoxyribonucleoside triphosphates (Promega), and reac-
tion buffer (50 mM KCl, 1.5 mM MgCl2, 0.1% Triton
X100, 10 mM Tris, and 8% dimethyl sulfoxide, with pH
9.0 at 25C) in 10-ml glass capillaries (Idaho Technology).
Amplification of insertion-containing exon 4 of
CYBB.—Products of the insertion-containing exon 4 from
the patient were obtained, with primers 5′-GTTAACAA-
TTACTATTCCATTCTTTCCCCC-3′ and 5′-CTATGA-
ATAGAGGGAACTCCCTGGTTCCAAG-3′, by use of
the Expand Long Template PCR System (Roche), accord-
ing to the manufacturer’s recommendations. In brief, the
region of interest was amplified by Expand Long Template
PCR on a PTC-0220 Peltier Thermocycler (MJ Research),
with 50–200 ng of genomic DNA as a template, in a total
reaction volume of 20 ml. The PCR was run with the
following settings: denaturing at 94C for 30 s, anneal-
ing at 56C for 40 s, and 30 cycles of extension at 68C
for 2 min.
Amplification of LRE3 from both the mother and
the patient.—The unique primers LRE3F (5′-ATTTGC-
GGCCGCTACCCCCTACTGTTGTGCCTTG-3′) and
LRE3R (5′-CGTCTACCGAAAGTCCATACTACCC-3′)
were designed using the chromosome 2 sequence from
AC067958 (GenBank). The first primer has a NotI site
at the 5′ end for cloning. Three additional unique pairs
were also designed to verify that LRE3 was present in
the sequence on AC067958 (GenBank). The ∼7,750-bp
product was amplified by use of the Expand Long Tem-
plate PCR System (Roche), according to the manufac-
turer’s recommendations. In brief, the 7.7-kb region was
amplified on a PTC-0220 Peltier Thermocycler (MJ Re-
search), with 50–200 ng of genomic DNA as a template,
in a total reaction volume of 20 ml. The PCR was run
with the following settings: denaturing at 94C for 30
s, annealing at 67C for 40 s, and 30 cycles of extension
at 68C for 6 min.
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Polymorphism Studies
The presence or absence of LRE3 in 23 individuals
from five different ethnic groups was determined using
a two-reaction, three-primer technique (Boissinot et al.
2000). The Expand Long Template PCRs were per-
formed in a PTC-0220 Peltier Thermocycler (MJ Re-
search), with 50–200 ng of genomic DNA as a template
in a total reaction volume of 20 ml. The PCR was run
with the following settings: denaturing at 94C for 30
s, annealing at 64.8C for 40 s, and 30 cycles of ex-
tension at 68C for 2 min. In brief, in the first reaction,
two unique flanking primers, A (5′-TTCCACCTCTGT-
GGTATCTATGGTC-3′) and C (5′-CATGACAATGG-
TCTGGGCAGTG-3′), were used to yield a ∼1,350-bp
product, in the absence of the element; in the second
reaction, the unique A primer and a reverse primer B
in the 5′ section of the L1 element (5′-TGTGGGATAT-
AGTCTCGTGGTGC-3′) were used to yield a ∼1,330-
bp product, in the presence of the element.
Southern Blotting
Southern blotting, with 8 mg of genomic DNA, was
performed as described elsewhere (Sambrook et al. 1989).
Cloning of LRE3
The single band obtained with primers LRE3F and
LRE3R was cut from a 0.7% agarose gel and was pu-
rified using a Gene Clean Spin kit (BIO 101). The band
was digested with NotI (in LRE3F) and BstZ17I (in the
3′ end of the L1 element). The full-length LRE3 frag-
ment, as a NotI/BstZ17I fragment, was swapped into
pL1RP-EGFP (with BstZ17I) (full-length L1RP element
tagged with the EGFP (enhanced green fluorescent pro-
tein) retrotransposition cassette; the pL1RP-EGFP con-
struct was the same as that described by Ostertag et al.
[2000] except that it was modified to contain an intact
BstZ17I site), to produce pLRE3-EGFP. This clone was
then tested for retrotransposition activity in a cell culture
assay.
Sequencing and Sequence Analysis
Clones and purified PCR products were sequenced us-
ing L1-specific or 3′ transduction–specific primers. Each
sequencing reaction contained ∼50 ng of PCR product or
∼500 ng of plasmid DNA and ∼3.2 pmol of oligonu-
cleotide primer. All sequencing was performed on ABI
3100 automated sequencers.
Retrotransposition Assay
Constructs pL1RP-EGFP, pL1RP(JM111)-EGFP (Oster-
tag et al. 2000), and pLRE3-EGFP were assayed for
retrotransposition activity in human 143B TK osteo-
sarcoma cells. Cell culture, transfection of cells, antibi-
otic selection, and flow cytometry were performed as
described elsewhere (Ostertag et al. 2000).
Results
CGD is a disorder that is caused by a deficiency in the
enzyme NADPH oxidase, which creates the reactive ox-
ygen species that are used by phagocytes to kill bacteria
and fungi. CGD is characterized by repeated infections.
Age at onset and phenotype are quite variable. NADPH
oxidase is composed of subunits that are encoded by
several different genes. Defects in the X-linked gene
CYBB, which encodes the gp91phox subunit of cyto-
chrome b558, are the most common cause, but other au-
tosomal forms exist (Roos et al. 1996). Analysis of the
patient’s granulocyte function revealed a normal chemo-
tactic response but a reduced intracellular killing of
Staphylococcus aureus (in the patient’s granulocytes,
57% of the bacteria were killed after 30 min, whereas,
in granulocytes from a control individual, 95% were
killed after 30 min) and a greatly reduced oxygen con-
sumption after addition of serum-treated zymosan (in
the patient, 0.6 nmol/106 cells; in the control individual,
7.2 nmol/106 cells). A negative NBT test and the absence
of cytochrome b558 in both whole cells and Triton
X100–extracted cells confirmed the diagnosis of CGD.
Failure to complement the patient’s oxidase system in
monocytes with that of a known patient with X-linked
CGD indicated the presence of a defect in the X-linked
gene CYBB.
A Southern blot of EcoRI-digested genomic DNA
probed with CYBB coding sequence (fig. 1A) revealed
an increase of ∼2 kb in the fragment that comprises
exon 4 of CYBB. The aberrant band was not seen in
either the patient’s mother or an unrelated control in-
dividual (fig. 1A); the patient’s father was unavailable
for analysis.
To confirm the results of the Southern blot, we am-
plified exon 4 in the patient, his mother, and an unre-
lated control individual (fig. 1B). The patient lacked a
normal exon 4 product but had an exon 4 that con-
tained an extra 2,105 bp, which indicates that the pa-
tient had one X chromosome and that it contained an
abnormal exon 4 of CYBB. Sequencing of the abnormal
PCR product revealed an insertion, comprising the final
1,722–1,724 bp of an L1 element, followed by a 280-
bp 3′ transduction. When compared with L1RP, the most
active element yet tested in the cell culture assay, the L1
fragment was found to contain a single-nucleotide
change in the 3′ UTR. The 3′ transduction was composed
of a 21-bp polyA tail followed by 259 bp with no ho-
mology to L1 or CYBB sequences. This sequence was
followed by a polyA tail of 101 bp that led directly to
the remainder of exon 4 of CYBB. Since the 5′ two bases
of the insertion were both A, it was impossible to de-
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Figure 1 Insertion analyses. A, CYBB-specific Southern blot
with EcoRI-digested DNA—from an unrelated control individual, the
patient’s mother, and the patient—demonstrating the shift, in the pa-
tient’s sample, of the exon 4–containing fragment. The sizes of the
wild-type bands are given; the arrow (R) indicates the aberrant band.
The probe was constructed with coding cDNA of CYBB as template.
B, Expand Long Template PCR of exon 4, in the patient, the patient’s
mother, and an unrelated control. The arrows (r) indicate markers in
the ladder.
termine whether they constitute a 2-bp TSD within a
2,103-bp insertion or whether they are part of a 2,105-
bp insertion without a TSD (fig. 2). The 5′ portion of
the transduced sequence contained an imperfect 29-re-
peat GAAA section. However, the final 153 bp con-
tained unique sequence. A BLAST search of the human
genome, for the entire 153-bp unique sequence, pro-
duced one exact match, AC067958 (GenBank), on chro-
mosome 2q24.1.
The AC067958 sequence (GenBank) contained a
slightly different imperfect GAAA repeat section, up-
stream from the unique sequence, but no L1 sequence.
Because active L1 elements are often polymorphic, we
assumed that the precursor (i.e., LRE3) was absent from
the Human Genome Project sequence. PCR using four
unique primer pairs showed that, in this region, the
patient’s mother was homozygous for a ∼6.1-kb LRE3
allele, whereas the patient was heterozygous (fig. 3).
These results were confirmed using a third primer in-
ternal to the L1 element (data not shown).
On direct sequencing of the patient’s LRE3 PCR prod-
uct, the final 1,720 bp of L1 sequence were an exact
match of the insertion on the X chromosome (fig. 2).
However, the imperfect GAAA repeat section 3′ from the
patient’s LRE3 allele had 28 repeats, whereas his inser-
tion had 29 repeats. We hypothesized that the mother
had a 29-repeat LRE3 allele that was the actual precursor
to the insertion and a 28-repeat allele that was inherited
by the patient. After cloning the maternal LRE3 PCR
product, we sequenced 12 clones and found that seven
contained (GAAA)3TAAATAAAAAGAAAA(GAAA)8-
GAA(GAAA)11GAGAAAAGCAAAA (29 repeats) and
that five contained (GAAA)3TAAATAAAAAGAAAA-
(GAAA)8GAA(GAAA)10GAGAAAAGCAAAA (28 re-
peats). The sequence of the maternal 29-repeat LRE3
allele perfectly matched all 2,105 bp of the patient’s
insertion.
A small possibility exists that a 29-repeat LRE3 tran-
script from the father was carried in the sperm and that
the precursor to the insertion is paternal in origin. Since
the father was unavailable for analysis, we observed the
prevalence of the 29-repeat LRE3 allele in the white
population, the most prevalent ethnic group in the
Netherlands. Of 50 white haploid genomes, 9 contained
an LRE3 element. We used PCR to obtain the 3′ flank.
On sequencing, we discovered that all nine LRE3 ele-
ments were followed by different repeat sections and
that only one of the nine matched the patient’s 29-repeat
insertion. Thus, the allele frequency of the 29-repeat
LRE3 allele in whites is ∼1 in 50 haploid genomes, or
∼2%. Since the patient is heterozygous for LRE3, his
father has at least one chromosome 2 without an LRE3
allele. Therefore, if the father is white, then he has an
∼2% chance of having a 29-repeat LRE3 allele.
LRE3 is located on chromosome 2q24.1. Because of
the polymorphic, repeating nature of this location, it
is impossible to determine unambiguously the “empty
site,” the exact point of insertion, or the length of the
TSD. If we assume that an endonuclease-mediated in-
sertion occurred, then the most likely point of insertion
is 5′ from the (GAAA)n repeat at 5
′-TGTC/AAAAA-3′.
This point of insertion follows the consensus 5′-Py-Py/
AAAA-3′ sequence of the L1-endonuclease site (Cost and
Boeke 1998). The TSD would then be 28 bp—that is,
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Figure 2 Insertion sequence analyses. A, Schematic representation of the CYBB insertion. PTp important sequence of a PCR product
from the patient’s exon 4. B, CYBB-insertion sequence alignments. CYBB p GenBank sequence at the point of insertion, into exon 4, of
CYBB; PT p sequence of a PCR product from the patient’s CYBB exon 4 (which includes the disease-causing insertion); LRE3p sequence
of a PCR product from the patient’s chromosome 2q24.1; L1RP p GenBank sequence of the most active element known (the nucleotide
number of the adjacent base is given in parentheses). A possible 2-bp TSD in the disease-causing insertion is underlined; differences between
sequences are shaded; leader dots indicate sequence that is consistent with the L1RP sequence.
5′-AAAAAAAAAAAAAGAAAGAAAGAAA(G/T)AA-3′,
with one G/T base change near the 3′ end (fig. 4).
LRE3 has two ORFs, is a member of the Ta-1d subset
of human retrotransposons, and is 99.9% identical to
L1RP. Sequence comparison of LRE3 with L1RP showed
the following six differences: two in the 5′ UTR; one in
ORF1; one in the inter-ORF region; one, leading to an
amino acid substitution, in ORF2; and one in the 3′
UTR (fig. 4). The mother’s LRE3 alleles are identical
in sequence except for the 3′ flank.
Since LRE3 is 99.9% identical to L1RP, we predicted
that the two elements would have similar retrotranspo-
sition activity in the cell culture assay. To test this pre-
diction, we cloned both the mother’s and the patient’s
PCR products directly into the pCEP4 expression vector,
which contained an antisense EGFP sequence that was
disrupted by an intron in the same orientation as the
L1 element. On transfection into 143B TK osteosar-
coma cells, the EGFP retrotransposition marker is ex-
pressed only when the L1 is transcribed, the intron is
spliced out, and the EGFP gene is reverse transcribed
and integrated into the genome (Ostertag et al. 2000).
When tested, under the direction of their endogenous
L1 promoters, both the mother’s and the patient’s LRE3
alleles had retrotransposition activities ∼50% greater
than that of L1RP (fig. 5). LRE3 is therefore the most
active human L1 element yet characterized in a cell cul-
ture assay.
We assessed the frequency of LRE3 in the general
population, using DNA from 5 Indo-Pakistanis, 9 sub-
Saharan Africans, 5 Pacific Islanders, 4 Chinese, and 25
white individuals. One or two individuals of all ethnic
groups except the sub-Saharan Africans, in whom LRE3
was not found, were heterozygous for LRE3. In sum,
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Figure 3 Expand Long Template PCR with flanking primers,
demonstrating the presence or absence of LRE3 in the patient’s mother,
in the patient, and in an unrelated heterozygote. All bands were se-
quenced, to confirm findings.
Figure 4 LRE3 sequence analyses. A, Schematic representation of the LRE3 insertion into chromosome 2q24.1. LRE3 p important
sequence from LRE3. Potential TSDs are underlined; asterisks (*) are placed at locations where differences exist between LRE3 and L1RP. The
larger asterisk indicates an amino acid change. B, LRE3 sequence alignments. CHR2 p GenBank sequence’s “empty site” at the LRE3 locus;
LRE3 p sequence of a PCR product from both the patient’s chromosome 2q24.1 and the patient’s mother’s chromosome 2q24.1; L1RP p
GenBank sequence of the most active element known (the nucleotide number of the adjacent base is given in parentheses). A possible 28-bp
TSD of LRE3 is underlined; nucleotide differences are shaded; leader dots indicate sequence that is consistent with the L1RP sequence.
LRE3 was present in 16 of the 96 genomes, giving an
allele frequency of 0.17 and further confirming the re-
cent evolutionary nature of the Ta-1d subset (Boissinot
et al. 2000) (fig. 6).
Discussion
We used a unique polymorphic 3′ transduction to derive
evidence that LRE3 retrotransposed, into CYBB, in the
primary oocyte during maternal meiosis I. The patient’s
29-repeat CYBB insertion does not match his 28-repeat
LRE3 allele but does match the mother’s 29-repeat
LRE3 allele. Since the patient’s mother does not appear
to have the CYBB insertion, the simplest explanation is
that the 29-repeat LRE3 allele in the mother was tran-
scribed and retrotransposed into an X chromosome be-
fore the conclusion of maternal meiosis I. On ovulation,
the separation of homologous chromosomes occurred,
and both the 28-repeat LRE3 allele and the X chro-
mosome with the 29-repeat insertion became part of the
secondary oocyte, whereas the actual precursor 29-re-
peat LRE3 allele and the X chromosome without the
insertion were lost in the extruded polar body. At fer-
tilization, the sperm carried a Y chromosome and a copy,
lacking LRE3, of chromosome 2. The fertilized egg pro-
duced a male offspring with a single 28-repeat LRE3
allele on chromosome 2 and a 29-repeat insertion on
the X chromosome.
Retrotransposition during maternal meiosis I pro-
vides the simplest explanation for our data. Since ma-
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Figure 5 Example of flow-cytometry results. A live/dead gate was set by use of forward and sideward scatter of cells, and ∼10,000 live
cells were assayed for fluorescence. Cells within the M1 marker were counted as positive. The M1 marker was zeroed using a single JM111
clone (L1RP, with two disabling ORF1 point mutations) and a single L1RP clone (not shown) that lacked the 3,832-bp AflII fragment. Both
negative controls were assayed in triplicate; one L1RP clone was assayed in triplicate, as a positive control; two LRE3 clones, one derived from
maternal genomic DNA and another derived from patient genomic DNA, were assayed in triplicate. Numbers give the average number, over
three assays, of positive cells for each clone  1 SD.
ternal meiosis I occurs in every ovulating female and
lasts from birth to ovulation, a rare retrotransposition
event could take place at any time during this period.
However, other scenarios that require the occurrence of
an additional rare event are formally possible:
1. If the mother were mosaic, then the actual insertion
into the X chromosome could have taken place as early
as maternal embryogenesis. However, by PCR, we did not
find any evidence for maternal mosaicism of lymphocyte
DNA. In addition, at this time, there is no evidence that
retrotransposition occurs during embryogenesis.
2. The patient’s insertion could have come from his
own precursor; instability during retrotransposition or
replication at the polymorphic repeat locus could have
resulted in an altered LRE3 allele that matched a ma-
ternal sequence. However, any instability would have to
be very precise, since one specific maternal allele would
have been changed to match the other. The wide variety
of repeat formats found in the nine individuals tested
suggests that this is unlikely. Also, present knowledge
indicates that the process of retrotransposition appears
to be accurate. Two precursors of human L1 insertions
have been exact matches to their respective insertions
over a total of ∼6 kb (Dombroski et al. 1991; Holmes
et al. 1994).
3. The father had a small chance of carrying a 29-
repeat LRE3 allele and could have passed a lingering 29-
repeat LRE3 message, in his sperm, that retrotransposed
into the maternal X chromosome. This scenario would
require the confluence of three rare events: (a) he would
need to have the correct LRE3 message; (b) he would
need to pass a stable full-length L1 mRNA, in his sperm,
separate from its precursor chromosome; and (c) that mes-
sage would need to be reverse transcribed and inserted
into the mother’s X chromosome postfertilization.
Because of the relative rareness of these alternative sce-
narios, a retrotransposition event during maternal mei-
osis I is the most straightforward explanation for our
data.
From an evolutionary perspective, only retrotranspo-
sition in germ cells or germ cell precursors can be passed
on to progeny; somatic retrotransposition, on the other
hand, is an evolutionary dead end. The new insertion
cannot be passed on, and, if the insertion harms the
host, then the precursor to the insertion will not be
passed on. Although ORF1 expression has been de-
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Figure 6 Assay and gel analyses. A, Schematic representation of the polymorphism assay that was used to determine the absence or
presence of an element. B, Sample gel, showing results from 20 individuals of diverse ethnic backgrounds.
tected in somatic cells in mouse testis (Branciforte and
Martin 1994), the only known example of somatic ret-
rotransposition is an L1 insertion, into an APC gene,
resulting in colon cancer (Miki et al. 1992). Oncogen-
esis, however, is a multistep process, and the colon cell
may have been partially transformed at the time of ret-
rotransposition. Although there is no in vitro evidence
of retrotransposition in primary cell lines, retrotranspo-
sition is readily demonstrated in cultured transformed
cell lines (Moran et al. 1996).
LRE3, the precursor to the insertion, is the most active
human L1 element yet tested in our cell culture assay.
When active L1 elements are used to create an amino
acid consensus sequence for ORF1 and ORF2 (data not
shown), the proteins encoded by LRE3 ORF1 and ORF2
are exact matches. Therefore, LRE3 is the first element
tested that has a perfect amino acid consensus through
both ORF1 and ORF2. LRE3 and L1RP differ by one
silent change in ORF1, four changes in noncoding
regions, and one TrN amino acid change at position 5
of ORF2; however, LRE3 is 50% more active. Further
analysis may provide insight into domains that are im-
portant in the mechanism of retrotransposition.
The insertion, into exon 4, of the patient’s CYBB gene
appears to lack TSDs that have commonly been found
in retrotransposition events. TSDs result when the L1
endonuclease cuts the two DNA strands at the insertion
site in a staggered manner. At least two explanations
for the apparent lack of TSDs are possible: First, L1-
endonuclease–mediated insertion could produce very
short TSDs of two bases (AA) or even no TSDs (Jensen
et al. 1994); insertion, in this case, would have occurred
at 5′-TC^AA-3′, a potential L1-endonuclease site (fig. 2)
(Cost and Boeke 1998). Second, it has been proposed,
as an explanation for the rare cases of TSD-less L1
insertions, that L1 fragments play a role in the repair
of preexisting double-strand breaks (Mager et al. 1985;
Van de Water et al. 1998; Kondo-Iida et al. 1999;
Browning et al. 2001). Either hypothesis could explain
the findings in the patient.
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LRE3 is the second precursor L1 element that has
been characterized using flanking sequence transposed
in a de novo insertion (Holmes et al. 1994). Indeed,
LRE3 is only the third active precursor L1 locus that
has been characterized overall (hence, its designation as
“L1 retrotransposable element–3”). With the inclusion
of the full-length elements that were isolated from ge-
nome analysis and that have retrotransposition activity
in the cell culture assay (Moran et al. 1996; Ostertag
et al. 2000), there are now 10 active human L1 elements
known (Sassaman et al. 1997; Schwahn et al. 1998;
Kimberland et al. 1999).
Overall, 211 CYBB mutations are listed in the Hu-
man Gene Mutation Database. One deletion was a non-
homologous recombination that involves an L1 element
that lies 5 kb upstream from CYBB (Kumatori et al.
1998). In addition, there has been a previous L1 inser-
tion into an intron of CYBB (Meischl et al. 2000). More
than half of known recent human L1 insertions have
occurred in only three genes: CYBB, factor VIII, and
dystrophin (Ostertag and Kazazian 2001). It would be
interesting to determine whether these three genes are
L1 hotspots or whether this seeming cluster of L1 ac-
tivity is the result of an ascertainment bias.
The polymorphic 3′ transduction of this insertion has
allowed us to predict, with great confidence, both the
timing and the parental origin of an in vivo retrotrans-
position event. LRE3, presently the most active human
L1 element in cell culture, is also the first element with
an active amino acid consensus sequence for both ORFs.
It will be interesting to see whether departures from
consensus or changes in noncoding nucleotides will fur-
ther increase the retrotransposition activity of L1 ele-
ments. As the most active L1 element currently known,
LRE3 is now the best candidate for mutagenesis systems
and other molecular biology applications.
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